10th Mar 2008 09:30
Imaginatik PLC10 March 2008 Form TR-1 with annex. FSA Version 2.1 updated April 2007 For filings with the FSA include the annex For filings with issuer exclude the annex TR-1: Notifications of Major Interests in Shares 1. Identity of the issuer or the underlying issuer of Imaginatik Plcexisting shares to which voting rights are attached: 2. Reason for notification (yes/no) An acquisition or disposal of voting rights Yes An acquisition or disposal of financial instruments which may result in the acquisitionof shares already issued to which voting rights are attached An event changing the breakdown of voting rights Other (please specify):______________ 3. Full name of person(s) subject to notification Pfizer Inc.obligation: 4. Full name of shareholder(s) (if different from Pfizer Inc.3): 5. Date of transaction (and date on which the 06/03/2008threshold is crossed or reached if different): 6. Date on which issuer notified: 07/03/2008 7. Threshold(s) that is/are crossed or reached: 6% 8: Notified DetailsA: Voting rights attached to shares Class/type of Situation previous to the Resulting situation after the triggering transactionshares triggering transaction If possible useISIN code Number of Number of Number of Number of voting rights Percentage of voting shares voting shares rights rights Direct Indirect Direct Indirect GB00B1G2HX83 Less than Less than 8,035,885 8,035,885 6.45% 3% 3% B: Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration date Exercise/ conversion No. of voting rights Percentage of votinginstrument period/date that may be acquired rights (if the instrument exercised/converted) Total (A+B) Number of voting rights Percentage of voting rights8,035,885 6.45% 9. Chain of controlled undertakings through which the voting rights and /or thefinancial instruments are effectively held, if applicable: Proxy Voting: 10. Name of proxy holder: 11. Number of voting rights proxy holder will ceaseto hold: 12. Date on which proxy holder will cease to holdvoting rights: 13. Additional information: 14 Contact name: Roger J. Hill PhD Worldwide Business Development| Pfizer Inc.| 50 Pequot Ave.| New London CT 06320 | USA Email: [email protected] 15. Contact telephone name: Roger J. Hill PhD Office: 860 732 2365; fax: 860 732 7052 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
ABAL.LPFZ.L